Aldeyra Therapeutics (ALDX) Short-Term Debt issuances (2013)

Aldeyra Therapeutics (ALDX) posted Short-Term Debt issuances of $895833.0 for Q4 2013.

Aldeyra Therapeutics (ALDX) Short-Term Debt issuances (2013) Analysis & Trends

Aldeyra Therapeutics' Short-Term Debt issuances history runs 1 years deep, the most recent figure standing at $895833.0 for Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 102,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 58.20 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Aldeyra Therapeutics 95.00 Mn 95.00 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 895,833.00
Dec 31, 2013 895,833.00